登入選單
返回Google圖書搜尋
Delivering Clinical Practice Guideline - Concordant Care for PTSD and Major Depression in Military Treatment Facilities
Kimberly A. HepnerCoreen FarrisCarrie M. Farmer
出版RAND Corporation, 2017
主題Biography & Autobiography / MilitaryMedical / Health PolicyMedical / Military MedicinePsychology / Psychopathology / Post-Traumatic Stress Disorder (PTSD)Psychology / Psychopathology / Depression
ISBN08330974909780833097491
URLhttp://books.google.com.hk/books?id=c7iFtAEACAAJ&hl=&source=gbs_api
註釋Providing accessible, high-quality care for psychological health (PH) conditions, such as posttraumatic stress disorder (PTSD) and major depressive disorder (MDD), is important to maintaining a healthy, mission-ready force. It is unclear whether the current system of care meets the needs of service members with PTSD or MDD, and little is known about the barriers to delivering guideline-concordant care. RAND used existing provider workforce data, a provider survey, and key informant interviews to (1) provide an overview of the PH workforce at military treatment facilities (MTFs), (2) examine the extent to which care for PTSD and MDD in military treatment facilities is consistent with Department of Veterans Affairs/Department of Defense clinical practice guidelines, and (3) identify facilitators and barriers to providing this care. This report provides a comprehensive assessment of providers' perspectives on their capacity to deliver PH care within MTFs and presents detailed results by provider type and service branch. Findings suggest that most providers report using guideline-concordant psychotherapies, but use varied by provider type. The majority of providers reported receiving at least minimal training and supervision in at least one recommended psychotherapy for PTSD and for MDD. Still, more than one-quarter of providers reported that limits on travel and lack of protected time in their schedule affected their ability to access additional professional training. Finally, most providers reported routinely screening patients for PTSD and MDD with a validated screening instrument, but fewer providers reported using a validated screening instrument to monitor treatment progress.--